Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Bonfim, Carmem  [Clear All Filters]
2018
Portugal MEline Guer, Raboni SMra, Nogueira MBordignon, Vidal LRosele Ren, Dingueleski AHelena, Kluk E, Bonfim C, Ribeiro LLima, Torres-Pereira CCarvalho. High Frequency of Multiple HPV Types Detection in Fanconi Anemia Patients Oral Swabs. Transpl Infect Dis. 2018:e13030.
2020
Arcuri LJavier, Nabhan SKanaan, Loth G, Atta EHallack, Oliveira M, Nichele S, Araujo Rde Castro, Bonfim C. A case series of post-transplant cyclophosphamide in unrelated donor hematopoietic transplantation for aplastic anemia. Biol Blood Marrow Transplant. 2020.
Marinho DHespanha, Ribeiro LLima, Nichele S, Loth G, Koliski A, Mousquer RToassa Gom, Funke VAraújo Mo, Page K, Fasth A, Pasquini R, et al. The challenge of long-term follow-up of survivors of childhood acute leukemia after hematopoietic stem cell transplantation in resource-limited countries: A single-center report from Brazil. Pediatr Transplant. 2020:e13691.
Arcuri LJavier, Nabhan SKanaan, Cunha R, Nichele S, Ribeiro AAlice Feit, Fernandes JFolloni, Daudt LEsteves, Rodrigues ALuiza Melo, Arrais-Rodrigues C, Seber A, et al. Impact of CD34 cell dose and conditioning regimen on outcomes after Haploidentical donor hematopoietic stem cell transplantation with post-transplant cyclophosphamide for relapsed/refractory severe aplastic anemia: Haploidentical HCT with PTCy for SAA. Biol Blood Marrow Transplant. 2020.
Arnold SD, Brazauskas R, He N, Li Y, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, et al. The impact of donor type on outcomes and cost of allogeneic hematopoietic cell transplant for pediatric leukemia: a merged CIBMTR and PHIS analysis: Pediatric acute leukemia transplant risks and utilization. Biol Blood Marrow Transplant. 2020.
Fernandes JFolloni, Nichele S, Arcuri LJavier, Ribeiro L, Netto GZamperlini, Loth G, Rodrigues ALuiza Melo, Kuwahara C, Koliski A, Trennepohl J, et al. Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases. Biol Blood Marrow Transplant. 2020.
2021
Dimitrova D, Nademi Z, Maccari MElena, Ehl S, Uzel G, Tomoda T, Okano T, Imai K, Carpenter B, Ip W, et al. International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome. J Allergy Clin Immunol. 2021.
Jardim Tde Almeida, Jardim BAraújo, Breda GLuís, Bonfim C, Raboni SMara. Mortality among pediatric hematopoietic stem cell transplantation patients: Report from a single center in southern Brazil. Pediatr Transplant. 2021:e13944.
2022
Bonfim C, Nichele S, Loth G, Funke VAraújo Mo, Nabhan SKanaan, Pillonetto DVandresen, Lima ACardoso Ma, Pasquini R. Transplantation for Fanconi anaemia: lessons learned from Brazil. Lancet Haematol. 2022;9(3):e228-e236.
2023
Nichele S, Bonfim C, Junior LGD, Loth G, Kuwahara C, Trennephol J, Funke VAM, Marinho DE, Koliski A, Rodrigues AM, et al. Hematopoietic cell transplantation for telomere biology diseases: A retrospective single-center cohort study. Eur J Haematol. 2023.
Garcia-Rosa M, Abraham A, Bertaina A, Bhoopalan SVelan, Bonfim C, Cohen S, Dezern A, Louis C, Oved J, Pavel-Dinu M, et al. International society for cell & gene therapy stem cell engineering committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant. Cytotherapy. 2023.
Nassani M, Fakih REl, Passweg J, Cesaro S, Alzahrani H, AlAhmari A, Bonfim C, Iftikhar R, Albeihany A, Halkes C, et al. The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes. Front Oncol. 2023;13:1135160.
Klein OR, Bonfim C, Abraham A, Ruggeri A, Purtill D, Cohen S, Wynn R, Russell A, Sharma A, Ciccocioppo R, et al. Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering. Cytotherapy. 2023.